These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23271313)

  • 21. The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness.
    Oktem EO; Derle E; Kibaroglu S; Oktem C; Akkoyun I; Can U
    Neurol Sci; 2015 Jul; 36(7):1141-6. PubMed ID: 25575807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
    Rodriguez MJ; Potter E; Shen Q; Barker W; Greig-Custo M; Agron J; Loewenstein D; Duara R
    Alzheimers Dement; 2012 May; 8(3):211-8. PubMed ID: 22546353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
    Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
    Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.
    Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG
    Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Tsuboi Y; Dickson DW
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Qualitative and quantitative measurement of retinal nerve fiber layer in primary open angle glaucoma by optical coherence tomography].
    Liu X; Ling Y; Zhou W; Zheng X; Liang D
    Zhonghua Yan Ke Za Zhi; 2000 Nov; 36(6):420-4, 28. PubMed ID: 11853640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
    Quinn JG; Coulson DT; Brockbank S; Beyer N; Ravid R; Hellemans J; Irvine GB; Johnston JA
    Brain Res; 2012 Jun; 1459():71-80. PubMed ID: 22560502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal hemoglobin is reduced in Alzheimer's disease, argyrophilic grain disease, Parkinson's disease, and dementia with Lewy bodies.
    Ferrer I; Gómez A; Carmona M; Huesa G; Porta S; Riera-Codina M; Biagioli M; Gustincich S; Aso E
    J Alzheimers Dis; 2011; 23(3):537-50. PubMed ID: 21157025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal nerve fiber layer thickness in patients with Alzheimer disease.
    Kirbas S; Turkyilmaz K; Anlar O; Tufekci A; Durmus M
    J Neuroophthalmol; 2013 Mar; 33(1):58-61. PubMed ID: 22918296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.
    Ferrari L; Huang SC; Magnani G; Ambrosi A; Comi G; Leocani L
    J Alzheimers Dis; 2017; 56(3):1101-1107. PubMed ID: 28106555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
    Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
    Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD.
    Jellinger KA
    Parkinsonism Relat Disord; 2006 Mar; 12(2):119-20. PubMed ID: 16337163
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies.
    Kawamoto Y; Ito H; Ihara M; Takahashi R
    Neuroreport; 2012 Feb; 23(3):162-7. PubMed ID: 22273571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Greater attenuation of retinal nerve fiber layer thickness in Alzheimer's disease patients.
    Shi Z; Wu Y; Wang M; Cao J; Feng W; Cheng Y; Li C; Shen Y
    J Alzheimers Dis; 2014; 40(2):277-83. PubMed ID: 24413621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathology of Lewy body disorders.
    Kövari E; Horvath J; Bouras C
    Brain Res Bull; 2009 Oct; 80(4-5):203-10. PubMed ID: 19576266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia.
    Cormack F; Aarsland D; Ballard C; Tovée MJ
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):371-7. PubMed ID: 15065231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal nerve fiber layer thickness in Parkinson disease.
    Kirbas S; Turkyilmaz K; Tufekci A; Durmus M
    J Neuroophthalmol; 2013 Mar; 33(1):62-5. PubMed ID: 23100041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dementia with Lewy bodies.
    McKeith IG; Burn DJ; Ballard CG; Collerton D; Jaros E; Morris CM; McLaren A; Perry EK; Perry R; Piggott MA; O'Brien JT
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):46-57. PubMed ID: 12567332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Making the diagnosis of mixed and non-Alzheimer's dementias.
    Hansen LA; Crain BJ
    Arch Pathol Lab Med; 1995 Nov; 119(11):1023-31. PubMed ID: 7487402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
    Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
    Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.